Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 2/2022

01-06-2022 | NSCLC

Biographies

Published in: Cancer and Metastasis Reviews | Issue 2/2022

Login to get access

Excerpt

Misako Nagasaka, M.D., Ph.D., is an associate clinical professor in Thoracic Oncology for the Division of Hematology/Oncology, Department of Medicine at the University of California Irvine School of Medicine, and a member of the UCI Chao Family Comprehensive Cancer Center who specializes in the diagnosis and treatment of lung and thyroid cancer. She received her medical degree and Ph.D. from St. Marianna University School of Medicine in Kawasaki, Japan. She completed her residency in Internal Medicine at the Beth Israel Medical Center in New York City and her fellowship at the Barbara Ann Karmanos Cancer Institute and the Wayne State University in Detroit, Michigan. …
Metadata
Title
Biographies
Publication date
01-06-2022
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 2/2022
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-022-10038-2

Other articles of this Issue 2/2022

Cancer and Metastasis Reviews 2/2022 Go to the issue

EditorialNotes

Preface

Non-Thematic Review

Nanotechnology-aided advancement in the combating of cancer metastasis

Correction

Correction to: Connecting the human microbiome and pancreatic cancer

ReviewPaper

Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation

COMMENTARY

The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor

Non-Thematic Review

Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits